Edited highlights from last month's Keynote Healthcare Q&A at the Global Corporate Venturing Symposium 2012 with Merck's William Taranto and Cleveland Clinic's Tom Thornton.
William Taranto, managing director and head of Merck’s Global Health Innovation Fund, a $250m fund to look at health care investment technology.
Tom Thornton, general manager of innovation alliances at Cleveland Clinic, who has just joined them from the Kansas Bio-Authority.
James Mawson (right in picture): Describe yourselves and firms and how you build partnership in healthcare, please.
Bill Taranto (left in picture): The reason Merck moved into venture is that our CEO has a vision of Merck being…
